EVFM (Evofem Biosciences) OCF Margin %: 255.95% (As of Mar. 2026)


What is Evofem Biosciences OCF Margin %?

Evofem Biosciences EVFM -0.06% OCF Margin % is 255.95% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 960 Biotechnology companies, Evofem Biosciences ranks better than 67.5% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Evofem Biosciences's Cash Flow from Operations for the three months ended in Mar. 2026 was $2.30 Mil. Evofem Biosciences's Revenue for the three months ended in Mar. 2026 was $0.90 Mil. Therefore, Evofem Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was 255.95%.

As of today, Evofem Biosciences's current OCF Yield % is -21.71%.

The historical rank and industry rank for Evofem Biosciences's OCF Margin % or its related term are showing as below:

EVFM' s OCF Margin % Range Over the Past 10 Years
Min: -23504.26   Med: -233.71   Max: -9.87
Current: -1.24

During the past 13 years, the highest OCF Margin % of Evofem Biosciences was -9.87%. The lowest was -23504.26%. And the median was -233.71%.

EVFM's OCF Margin % is ranked better than
67.5% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs EVFM: -1.24

Evofem Biosciences OCF Margin % Related Terms

Evofem Biosciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Evofem Biosciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evofem Biosciences OCF Margin % Chart

Evofem Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,779.08 -418.19 -49.23 -20.06 -9.87

Evofem Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.27 -60.50 6.79 0.32 255.95

EVFM vs PTIX, ATXI, AGTX: OCF Margin % Comparison

For the Biotechnology subindustry, Evofem Biosciences's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evofem Biosciences OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evofem Biosciences's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Evofem Biosciences's OCF Margin % falls into.


Evofem Biosciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Evofem Biosciences's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.992/20.183
=-9.87 %

Evofem Biosciences's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=2.301/0.899
=255.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 255.95% mean?
Evofem Biosciences (EVFM) has a OCF Margin % of 255.95% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Evofem Biosciences and its competitors. According to the industry distribution chart, Evofem Biosciences ranks #312 out of 960 companies in the Biotechnology industry, placing it in the top 32.5%.
Is Evofem Biosciences' OCF Margin % too high?
Evofem Biosciences' current OCF Margin % is 255.95%. Based on the distribution chart, Evofem Biosciences ranks #312 out of 960 companies in the Biotechnology industry, which is above the industry midpoint.
How does Evofem Biosciences' OCF Margin % compare to PTIX and ATXI?
According to the Biotechnology industry distribution chart, Evofem Biosciences ranks #312 out of 960 companies for OCF Margin %. This puts Evofem Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Evofem Biosciences and its competitors. Evofem Biosciences's current OCF Margin % is 255.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evofem Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Evofem Biosciences (EVFM) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 12.8% below its estimated fair value. The current OCF Margin % is 255.95%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Evofem Biosciences (EVFM), the current OCF Margin % is 255.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evofem Biosciences Business Description

Address 7770 Regents Road, Suite 113-618, San Diego, CA, USA, 92122
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. The company's product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy.